Balyasny Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $142M | Sell |
|
|||||
|
2021
Q1 | $122M | Buy |
|
|||||
|
2020
Q4 | $51.5M | Buy |
|
|||||
|
2020
Q3 | $36.2M | Buy |
|
|||||
|
2020
Q2 | $16.4M | Buy |
|
|||||
|
2020
Q1 | $8.64M | Sell |
|
|||||
|
2019
Q4 | $34.2M | Buy |
|
|||||
|
2019
Q3 | $228K | Sell |
|
|||||
|
2019
Q2 | $5.98M | Sell |
|
|||||
|
2019
Q1 | $17.4M | Sell |
|
|||||
|
2018
Q4 | $37.5M | Buy |
|
|||||
|
2018
Q3 | $43.3M | Buy |
|
|||||
|
2018
Q2 | $18.8M | Sell |
|
|||||
|
2018
Q1 | $58.1M | Sell |
|
|||||
|
2017
Q4 | $147M | Buy |
|
|||||
|
2017
Q3 | $24.3M | Sell |
|
|||||
|
2017
Q2 | $22.9M | Buy |
|
|||||
|
2017
Q1 | $10.1M | Sell |
|
|||||
|
2016
Q4 | $26.2M | Buy |
|
|||||
|
2016
Q3 | $21M | Buy |
|
|||||
|
2016
Q2 | $11.6M | Buy |
|
|||||
|
2016
Q1 | $12.5M | Buy |
|
|||||
|
2015
Q4 | $8.38M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $6.33M | Sell |
|
|||||
|
2015
Q1 | $22M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $4.13M | Buy |
|